Columbia’s 2026 Session: Is S.53 the Final Hope for SC Medical Patients?

South Carolina is one of the few states without a legal medical cannabis program. The 2026 legislative session is beginning in Columbia, and patients and advocates are focused on Senate Bill 53 (S.53), known as the Compassionate Care Act. This bill would create a regulated medical cannabis system for the state. 

Supporters of this bill see it as a long-awaited step forward, while others question whether it will clear the remaining political barriers or not. Here is what S.53 proposes and where it stands in South Carolina’s cannabis reform debate.

SC’s Long Road Without Medical Cannabis

South Carolina has not legalized medical marijuana, which puts it among the few states without a medical cannabis law. Most cannabis and THC products are illegal under state law, except for a few low-THC hemp products. This has created confusion about what is legal and illegal. Some residents turn to Delta-8 or low-THC hemp products and still risk problems with law enforcement or workplace rules.

This gap is especially hard for patients with chronic pain, nausea, PTSD, and similar conditions. Without legal medical access, many people must use unregulated products or skip treatment entirely.

What Is S.53 and Who’s Behind It?

Senate Bill 53 is known as the South Carolina Compassionate Care Act. It was introduced by a group of state senators, including Tom Davis, on January 14, 2025. This bill is the latest version of a long-running effort to create a conservative and tightly regulated medical cannabis program that fits South Carolina’s political climate. Earlier versions passed the Senate but failed to advance in the House.

If approved, S.53 would allow patients with qualifying medical conditions to legally access cannabis products. The system would rely on licensed cultivation centers, therapeutic pharmacies, and physician oversight, similar to medical-only programs in other states.

Qualifying Conditions and Patient Access

Under S.53, patients would need a doctor’s certification to access medical cannabis. The bill limits eligibility to specific conditions, including:

• Cancer-related symptoms

• Multiple Sclerosis Spasticity

• Epilepsy and seizure disorders

• PTSD

• Chronic pain

• Autism-related symptoms

• Terminal illness with a life expectancy of under one year

• Conditions where opioids are the standard treatment

This approach is more restrictive than in many states. It focuses on serious and debilitating conditions rather than allowing doctors broad discretion.

Approved patients would receive a medical cannabis card and could buy tested products from licensed dispensaries. Smoking would not be allowed, but vaporized products and non-smoked options like tinctures and edibles would be permitted. The bill also bans home cultivation and requires a “bona fide physician-patient relationship”.

Regulated Market and Medical Cannabis Infrastructure

One of S.53’s main elements is the creation of a regulated medical cannabis market. The bill places oversight with the South Carolina Department of Public Health and the Board of Pharmacy. These agencies would be responsible for setting program rules, issuing licenses, and enforcing compliance across the state.

Licensed Medical Cannabis Facilities

The program would allow several types of licensed facilities to operate. These include:

• Cultivation centers that grow medical cannabis

• Processing facilities that produce standardized products

• Therapeutic cannabis pharmacies where patients purchase their medicine

• Independent testing laboratories would also be licensed to verify product safety and quality.

Product Safety and Professional Standards

All medical cannabis products would be required to meet strict safety rules. This includes child-resistant packaging and laboratory testing to confirm potency and purity. This is in line with standards used in other legal states. Pharmacists who dispense medical cannabis would also need ongoing, cannabis-specific training.

Goals of the Regulated System

Supporters argue that this structure would reduce diversion, improve product consistency, and ensure patients receive safe, tested medicine. If implemented, it would represent a major shift away from South Carolina’s current reliance on illegal or unregulated cannabis markets.

Political Support and Opposition

Public support for medical cannabis in South Carolina is strong. National surveys often show approval above 70%, which mirrors trends across the country.

Legislative Barriers at the State House

Support inside the State House is more complex. In past sessions, S.53 cleared the Senate but never reached a full House vote before time ran out. House committee leaders blocked debate, and resistance from conservative groups remained firm.

Debate Over the Scope of the Program

Law enforcement organizations and socially conservative lawmakers are still framing cannabis as a public safety issue. At the same time, some advocates argue for a broader medical program, including access to cannabis flower, which S.53 does not permit.

For patients and supporters, the key question is whether a narrow, tightly regulated system is better than having no legal medical access at all.

SC in the Broader Cannabis Landscape

Most U.S. states now have medical cannabis programs. By 2025, 39 states had made medical cannabis legal. This movement continues to grow across the country.

South Carolina is now one of the few states without a program. This puts pressure on local lawmakers, especially since neighboring states are expanding their laws.

Changes in federal law could also help. The government might reschedule cannabis soon. This would not make it legal nationwide, but it would make banking and medical research much easier for state programs.

Will S.53 Finally Pass in 2026?

Advocates see the 2026 session as a final chance for S.53 to pass. After years of failed votes, many people worry that future bills will not succeed.

Supporters believe the bill will pass this time. They point to strong public support, moving patient stories, and better rules for the program. However, critics disagree. They believe resistance from House leaders is still too strong.

To win, lawmakers must find a balance. They need to provide patient access while satisfying conservative concerns. This is a very difficult task in Columbia.

Conclusion

As the 2026 session continues in Columbia, S.53 is the main bill for medical cannabis reform. This bill is the best chance for patients to get legal access. If it passes, it will change South Carolina’s laws for many years. However, if it fails, patients will have to wait even longer for help.